commercialisation

Market Access

Chinese flag atop pills on black background

Is the next generation of Chinese biotech ready to go global...

Will Chinese biotechs continue to transfer most ex-China rights, or retain their strongest assets and compete internationally themselves?

Market Access

From first approval to lasting value: What sets successful e...

Approval may validate the science, but it does not secure commercial success. That outcome is determined by the decisions made before launch.

Market Access

Blue and white pills in pharma manufacturing line

Pharma’s most expensive question is the last one asked

Whether a drug can secure reimbursement is pharma's billion-dollar question, and the companies that succeed will be those that answer it sooner.

Sales & Marketing

Omnideployment concept, female hand holds digital globe and connected networks of men and women

Beyond omnichannel: Why pharma commercialisation must shift ...

We need to step away from the passive, broad concept of omnichannel and adopt a far more active, disciplined framework: omnideployment.

News

Roche’s Genentech strikes $2.3bn deal for Hanmi obesity drug...

Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity drug HM17321.

Market Access

The new commercialisation playbook: What BIO 2026 taught eme...

BIO International focused on how emerging biotech companies should approach their first product launch outside the United States, typically in Europe.

Is the next generation of Chinese biotech ready to go global...

From first approval to lasting value: What sets successful e...

Pharma’s most expensive question is the last one asked

Beyond omnichannel: Why pharma commercialisation must shift ...

Roche’s Genentech strikes $2.3bn deal for Hanmi obesity drug...

The new commercialisation playbook: What BIO 2026 taught eme...

argenx's Forte acquisition delivers coeliac trial win

Discover a new era of healthcare panel engagement: Grounded ...

commercialisation

Editor's Picks